SCHEMBL26581069

SCHEMBL26581069

Cc1cc(C(=O)O)cc2c1OCO2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
MAPK1 P28482 1/20 0.53
SRD5A2 P31213 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TPMT P51580 1/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
CTNNB1 P35222 2/20 0.38
WNT3A P56704 2/20 0.38
HPGD P15428 2/20 0.38
NPC1 O15118 5/20 0.37
RAB9A P51151 4/20 0.37
CASP3 P42574 2/20 0.37
SENP7 Q9BQF6 2/20 0.37
SENP6 Q9GZR1 1/20 0.37
PKM P14618 1/20 0.36
NQO2 P16083 1/20 0.36
PAX8 Q06710 1/20 0.36
KLF5 Q13887 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3350012 0.86 PLK1 (0.44) ALDH1A1MAPK1SMN1; SMN2KDM4ETPMT
SCHEMBL6345461 0.86 KMT2A (0.42) ALDH1A1MAPK1SMN1; SMN2KDM4EMEN1
SCHEMBL17714985 0.81 RAB9A (0.49) ALDH1A1SMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL1811267 0.80 ALDH1A1 (0.55) ALDH1A1MAPK1SRD5A2SMN1; SMN2KDM4E
SCHEMBL25391509 0.79 ALDH1A1 (0.53) ALDH1A1MAPK1SRD5A2SMN1; SMN2KDM4E
SCHEMBL13671456 0.79 ALDH1A1 (0.53) ALDH1A1MAPK1SRD5A2SMN1; SMN2KDM4E
SCHEMBL3705853 0.79 ALDH1A1 (0.53) ALDH1A1MAPK1SRD5A2SMN1; SMN2KDM4E
SCHEMBL23809420 0.78 ALDH1A1 (0.49) ALDH1A1MAPK1SRD5A2SMN1; SMN2MEN1
SCHEMBL4938172 0.78 PLK1 (0.55) ALDH1A1MAPK1SMN1; SMN2KDM4ETPMT
SCHEMBL4422910 0.76 ALDH1A1 (0.46) ALDH1A1MAPK1SRD5A2SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 ALDH1A1 2556/4885MAPK1 1843/4885SRD5A2 4675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.